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Abstract Incubation of HepG2 cells in the presence of dibutyryl 
CAMP (db-CAMP), a cell permeable analogue of cyclic AMP, or 
forskolin, an agent which elevates intracellular CAMP, resulted 
in a 50% decrease in apoE mRNA levels within 24 h. Results of 
nuclear run-on transcription assays showed that db-CAMP down- 
regulates apoE gene expression at the transcriptional level. By 
transfection analysis with a plasmid containing the -614/+804 
human apoE gene fused to the secreted placental alkaline 
phosphatase @PAP) reporter gene, we showed that the SPAP 
activity was decreased by 50% when HepG2 cells were incubated 
in the presence of db-cAMP or forskolin, indicating that this 
promoter region mediated this negative effect. In contrast, when 
the smaller fragment -200/+1 of apoE promoter was linked to 
the CAT reporter gene, db-CAMP treatment of HepG2 cells 
resulted in a 2-fold increase in CAT activity, suggesting that 
positive CAMP-responsive elements were present in the proximal 
apoE promoter. These data indicate that transcriptional 
modulation of apoE gene expression by agents known to elevate 
the intracellular CAMP level is complex and involves several 
negative and positive elements located in the -614 to +I304 
region of the apoE gene whose global effect is negative on apoE 
gene transcription. 
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1. Introduction 
Apolipoprotein E (apoE) is a major structural component 
of various classes of mammalian lipoproteins, including chy- 
lomicron remnants, very low density lipoproteins, intermedi- 
ate density lipoproteins, and high density lipoproteins. ApoE 
plays an important role in the redistribution of cholesterol 
and other lipids between peripheral tissues and the liver. It 
mediates the cellular uptake of specific lipoproteins, especially 
chylomicron remnants and intermediate density lipoproteins, 
via the interaction with low density lipoprotein receptors and 
distinct hepatic receptors [l]. Transgenic mice that overexpress 
apoE [2] or present apoE deficiency [3] have provided valuable 
information about the metabolic and anti-atherogenic role of 
apoE, indicating the importance of regulation of apoE synthe- 
sis. The major site of apoE synthesis is the liver [4]. However, 
unlike most apolipoproteins which are synthesized only in the 
liver and intestine, apoE is also synthesized in a number of 
peripheral tissues, such as adrenal, testis, ovary, spleen, kid- 
ney, and lung [4-71. ApoE synthesis has been shown to be 
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regulated in hepatic and steroidogenic cell types by nutritional 
or hormonal factors or during development [4,8-121, but the 
molecular mechanisms of apoE regulation by transduction of 
extracellular signals via second messengers remain obscure. A 
previous study in our laboratory has demonstrated that glu- 
cagon modulates apoE mRNA level in rat liver during devel- 
opment or when cyclic AMP (CAMP) was injected repeatedly 
into living rats [13]. Glucagon might modulate the expression 
of the apoE gene by the protein kinase A (PKA)-mediated, a 
process already described for other genes [14]. Since CAMP- 
dependent protein kinase has been implicated in lipid homeo- 
stasis [15,16] and lipoprotein metabolism [17,18], we are not 
certain whether changes in apoE gene expression observed in 
in vivo experiments are due to a direct effect of CAMP itself or 
to secondary changes in lipoprotein metabolism. The purpose 
of this study was to investigate the direct influence of CAMP 
on hepatic transcription of the apoE gene. We used the 
HepG2 cell line which provides a convenient model system 
to study the regulation of apolipoprotein gene expression in 
human liver [12,19,20]. 
In this paper, we demonstrate that CAMP exerts a repres- 
sive effect on apoE gene transcription. Using chimeric report- 
er gene constructs, we observed that the negative effect of 
CAMP is mediated by elements(s) located between -614 to 
+804 in the apoE gene and we provide evidence that the 
minimal promoter -2OO/+l of the apoE gene contains ele- 
ment(s) which can respond positively to CAMP. Our results 
suggest that regulation of apoE gene transcription by CAMP 
is a result of a complex pattern of interactions between 
CAMP-sensitive nuclear factors, and positive and negative reg- 
ulatory elements in the -614/+804 region of the apoE gene. 
2. Materials and methods 
2.1. Materials 
Dulbecco’s modified Eagle’s medium (DMEM), L-glutamine, anti- 
biotics, fetal calf serum and Dulbecco’s phosphate-buffered saline 
(PBS) were obtained from Gibco BRL (European division). [a- 
32P]dCTP, [y-32P]ATP, [a-“‘P]UTP, [35S]methionine (1000 Ci/mol) 
Nylon Hybond N+, Royal X-Omat films and multiprimer kits were 
purchased from Amersham International. We used P-galactosidase 
expression vector pCHll0 from Pharmacia while dibutyryl cyclic 
AMP, p-nitrophenyl phosphate (alkaline phosphatase substrate) and 
all other products were purchased from Sigma. Anti-(human apoE) 
antiserum was purchased from Immuno France. 
2.2. Cell culture 
HepG2 cells were cultured at 37°C in a humidified atmosphere of 
5% COs, 95% air. HepG2 cells were grown in DMEM containing 10% 
fetal calf serum (FCS), 2 mM r.-glutamine and antibiotics (penicillin, 
streptomycin). 24 h before hormonal treatment, when HepG2 cells 
were confluent, the cells were washed twice with PBS (pH 7.4) and 
further maintained in DMEM serum-free medium. 
2.3. RNA extraction and analysis 
After extraction according to the method of Chomczynski and Sac- 
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chi [21], total RNA was analyzed by Northern blotting as previously 
described [12]. The blots were hybridized with apoE cDNA probe 
labeled with [a-32P]dCTP by random priming and rehybridized to a 
28s rRNA probe labeled with T4 polynucleotide kinase and 
[y-32P]ATP to standardize the amount of mRNA in each lane. 
2.4. Protein labelling and immunoprecipitation 
HepGs cells were cultured in DMEM with 2% (w/v) bovine serum 
albumin for 24 h. The cells were then incubated in DMEM plus 
albumin in the presence or in the absence of 10m4 M db-CAMP for 
24 h. To study the synthesis of apolipoprotein E, the cells were 
washed three times with 2 ml methionine-free minimum essential 
medium and incubated for 3 h with the same medium containing 
[35S]methionine (70 @/dish). Cell lysates and media were subjected 
to immunoprecipitation with anti-(human apoE) antiserum, followed 
by 10% SDS-PAGE. Autoradiograms show bands with the appropri- 
ate mobilities of apoE isoforms as previously described [12]. The 
bands of apoE isoforms were quantified by densitometric scanning. 
2.5. Nuclear isolation and run-on assays 
The rate of apoE gene transcription, 24 h after db-CAMP treatment, 
was measured using run-on assay. Nuclei were prepared from HepG2 
cells according to Marzluff et al. [22]. Nuclear isolation and hybridi- 
zation of nuclear transcripts to immobilized DNA were performed as 
described [ 121. 
2.6. Plasmid constructs 
The apoE reporter gene chimeric constructs were synthesized by 
inserting different fragments of the human apoE gene into a SPAP 
or a CAT reporter vector using standard molecular biology tech- 
niques, An SpeIIHindIII 1.4 kb fragment covering the -614 to 
+804 region of the apoE promoter was obtained by polymerase chain 
reaction (PCR) from human genomic DNA as template and cloned 
into Spel and Hind111 in the polylinker region of pSPAP vector 
(generously provided by Glaxo-Les Ulis), upstream to the secreted 
placental alkaline phosphatase (SPAP) gene. 
The -200 to +1 region of the apoE promoter was obtained with a 
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Fig. 1. Effect of db-CAMP on the apoE gene transcription rate. 
HepG2 cells were maintained in serum-free medium for 24 h and 
were incubated in the presence or absence of 10e4 M db-CAMP for 
another 24 h. Nuclei were then prepared and used for the in vitro 
transcription assay as described in Section 2. Equal amounts 
(50x lo6 cpm) of 32P-labeled RNA were hybridized to nitrocellulose 
filters containing 10 pg of linearized plasmids bearing apoE, 
GAPDH cDNA sequences, and pUCl9 as a background control. 
(A) This autoradiogram is representative of two separate experi- 
ments. (B) The amount of each band was analyzed using a videoco- 
py/Densylab system from Bioprobe and the data shown are the re- 
sults of the apoE/GAPDH ratio after subtraction of background 
radioactivity hybridized to pUCl9. 
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Fig. 2. Effect of db-CAMP on CAT activity in HepG2 cells trans- 
fected with apoE promoter (-200/+1)-CAT reporter gene construct. 
HepG2 cells transiently transfected with the apoE (-200/+1)-CAT 
construct were grown in serum-free medium 24 h and treated with 
or without db-CAMP 10m4 M for 24 h. CAT activity was measured 
as described in Section 2 and normalized to the B-galactosidase ac- 
tivity to correct for differences in transfection efficiency. Data repre- 
sent mean f S.D. from two separate experiments performed in tripli- 
cate. 
set of five double-stranded synthetic oligonucleotides (Applied Biosys- 
terns, model 380-B) named A-E after annealing between each oligo- 
nucleotide and its complement. Fragments A and E contained the 
Hind111 and XhoI sites, respectively. The five fragments were then 
ligated into the pUC-SH-CAT vector [23] digested by XhoI and Hin- 
dIII. All constructions were confirmed by DNA sequencing. 
2.7. Ceil transfection, CAT and SPAP assays 
Transient transfections of HepG2 cells were performed by the cal- 
cium phosphate co-precipitation method, as previously described [24]. 
Chloramphenicol acetyltransferase (CAT) activity was determined by 
acetylation of [14C]chloramphenicol (Amersham) followed by thin- 
layer chromatography, as previously described [24]. For secreted pla- 
cental alkaline phosphatase (SPAP) assays, on the day following 
transfection, HepG2 cells were trypsinized and seeded on well-titer 
microplates (microdish well-plate 96F). Secretion medium was used 
to measure SPAP activity and total cellular protein was determined. 
SPAP activity was measured as previously described [25]. 
3. Results and discussion 
To assess whether cyclic AMP plays a role in apoE gene 
expression, we first examined the effects of two agents, for- 
skolin and dibutyryl CAMP (db-CAMP), which increase the 
intracellular CAMP levels or mimic the action of CAMP in 
various cell types. 
When HepG2 cells were exposed for 24 h to db-CAMP 
(10m4 M) or forskolin ( 10M6 M) after incubation in control 
medium, the apoE mRNA level was reduced by 40-50% (Ta- 
ble 1). The decrease in apoE mRNA induced by db-CAMP or 
forskolin was observed after a lag period and the effect was 
only significant after 24 h of treatment (data not shown). 
Apolipoprotein E synthesis was assessed by incubating 
HepG2 cells in the presence or absence of db-CAMP for 24 
h then by performing a pulse of [35S]methionine. Quantitation 
by laser scanning densitometry indicated that the amount of 
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Table 1 
Etrect of db-CAMP and forskolin on apoE mRNA in Hep G2 cells 
Control db-CAMP Forskolin 
Relative apoE mRNA level 1.20+0.03 0.72 + 0.01 @ < 0.01) 0.68 + 0.04 @ < 0.01) 
HepG2 cells were maintained for 24 h in serum-free medium and then incubated for 24 h in the absence (control) or presence of lO-4 M db-CAMP 
or 10e6M forskolin. Total RNA was extracted and analyzed by Northern blotting as described in Section 2. Data obtained by densitometric 
scanning was normalized for the 28s signal and given in arbitrary units. Results are the means +_ SD. of three independent experiments performed 
in duplicate. 
Table 2 
Incorporation of [35S]methionine into cellular and extracellular immunoprecipitated apoE 
Control db-CAMP Inhibition (%) 
Cells 17.1 f 1.3 9.5 f 1.2 (p < 0.01) 44 
Media 62.9 f 0.7 47.0 f 4.5 0, < 0.05) 30 
HepG2 cells were incubated in the presence or absence of db-CAMP for 24 h and then incubated with [35S]methionine (70 uCi/dish) for 3 h. Media 
and cell lysates were immunoprecipitated with a specific anti-(human apoE) antiserum and analysed by 10% SDS-PAGE. The intensity of apoE 
bands was analysed by scanning densitometry. Values shown denote the amount of apoE (in arbitrary units, means f SD.). Two independent 
experiments were performed in duplicate. 
Table 3 
Effect of db-CAMP and forskolin on SPAP activity in HepG2 cells transiently transfected with apoE promoter (-614/+804)-SPAP reporter 
gene construct 
Control db-CAMP Forskolin 
Relative pE-SPAP activity 0.59+_0.05 0.28 f 0.06 (p < 0.01) 0.38 t 0.03 (p < 0.05) 
HepG2 cells transiently transfected with the apoE (-614/+804)-SPAP construct were trypsinized and seeded in microwell plates. The following day, 
cells were placed in serum-free medium for 24 h and incubated in the same medium with or without the addition of 10d4 M db-CAMP or 10e6 M 
forskolin. SPAP activity was determined as described in Section 2 and normalized to total cellular protein content. Data represent mean + S.D. 
from three experiments performed in quadriplicate. 
apoE secretion and cellular apoE were significantly reduced 
by 30 and 45%, respectively (Table 2). 
When injected in vivo, glucagon or db-CAMP increased 
hepatic apoE mRNA levels. The discrepancy between in 
vivo experiments and the observed data herein results from 
the secondary secretion of various hormones when the rats 
were treated with glucagon or db-CAMP. For example, we 
have previously shown that hepatic levels apoE mRNA are 
correlated with the glucagonlinsulin ratio rather than plasma 
glucagon levels, itself [ 131. 
In order to determine whether the observed changes in 
steady-state levels, of apoE mRNA were due to changes in 
the transcription rate, run-on assays were performed on 
HepG2 cells using nuclei from either control cells or cells 
treated with db-CAMP for 24 h. Quantitation of autoradio- 
grams (Fig. 1 A) by scanning densitometry after correction for 
GAPDH gene transcription showed that the apoE gene tran- 
scription rate was reduced 2-fold at 24 h (Fig. 1B). This result 
indicates that the decrease in the rate of apoE gene transcrip- 
tion could totally account for the change in steady-state level 
of apoE mRNA. 
In eukaryotes, the signal transduction pathways that in- 
volve CAMP induce phosphorylation of transcription factors 
that interact promoter sequences termed CAMP responsive 
elements (CREs) [26]. Several regulatory sequences have 
been identified in the promoter region of apoE gene by nucle- 
ar footprint and electrophoretic mobility shift assays [27,28]. 
Inspection of these sequences by computer-aided analysis re- 
vealed three consensus CREs [TGACG (C/T)(C/A)(G/A)] as 
putative &-acting elements in the promoter region localized 
at positions [-498 to 4911, [-444 to -4371 and [-95 to -881 
[29]. Consequently, we investigated whether this region is in- 
volved in the CAMP effect. We first transfected HepG2 cells 
with a plasmid containing the -614/+804 fragment of the 
human apoE gene fused to the SPAP reporter gene (p[-6141 
+804]-apoE-SPAP). After 24 h of either db-CAMP or forsko- 
lin treatment, we observed a decrease in SPAP activity by 50 
and 40% of the activity of untreated HepG2 cells, respectively 
(Table 3). This inhibition is of the same order of magnitude as 
that observed for the steady-state mRNA level (Table 1) or 
transcription rate (Fig. l), suggesting that complete respon- 
siveness to CAMP is mediated by the -614/+804 fragment of 
apoE gene. 
In a second set of experiments, we transfected HepG2 cells 
with the plasmid containing the CAT-reporter gene under the 
control of the -200 to +l region of the apoE gene promoter 
(p[-200;+1] apoE CAT). This construct was described to be 
necessary and sufficient for optimal expression in the HepG2 
cell line [30]. Surprisingly, we observed a 2-fold increase in 
CAT activity in transfected cells treated for 24 h with db- 
CAMP compared with control transfected cells (Fig. 2). Since 
db-CAMP had no specific effect on the original cloning vector 
pUC-SH-CAT (data not shown), these results reveal the pres- 
ence of one or several elements which respond positively to 
CAMP in -2OO/+l region of apoE promoter. Moreover, these 
results suggest that sequences located upstream or down- 
stream from this region, act to block or suppress the CAMP 
inducible activity in the proximal -200/+1 apoE promoter. 
An increased intracellular CAMP level as a result of an 
extracellular signal activates protein kinase A (PKA), which 
in turn modifies the pattern of cellular protein phosphoryla- 
tion [31]. The positive effect of db-cyclic AMP on (p[-200/+1] 
apoE-CAT) activity might be the result of transactivation by 
the nuclear factor CREB [32] after activation by phosphoryla- 
tion [33,34]. The global negative effect of CAMP on either 
apoE mRNA steady-state, apoE gene transcription rate or 
158 
(p[-614/+804] apoE-SPAP) activity indicates that other 
CAMP-stimulated factors also counteracted the CREB effect 
on the -2OO/+l apoE minimal promoter. Several CRE bind- 
ing repressor families have been described. They include 
ICER proteins which could act as powerful repressors and 
CREM a, B and y which are constitutionally present and 
whose activity can be modulated by phosphorylation [35]. 
These factors might either occupy CRE sites present in 
-614/+804 apoE promoter as homodimers in the active 
form or dimerize with activators present on the CRE site of 
the minimal -2OO/+l promoter, blocking them by the forma- 
tion of non-functional heterodimers [36]. 
In conclusion, complex regulation of apoE gene transcrip- 
tion by CAMP via PKA activation is likely to be determined 
by a combined action on the activator elements, present in the 
proximal region -2OO/+l and repressor elements present up- 
stream and downstream from this region with a dominant 
activity. The next step will be to identify the specific DNA 
sequence(s) and the regulatory proteins responsible for this 
complex effect of CAMP on apoE gene transcription. 
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